Fan Feng Selected Research

Pharmaceutical Preparations

6/2020	Polydatin induces apoptosis and autophagy via STAT3 signaling in human osteosarcoma MG-63 cells.
2/2019	Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
8/2018	Analysis of mulberry leaf components in the treatment of diabetes using network pharmacology.
11/2017	A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma.
7/2016	Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
6/2015	Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fan Feng Research Topics

Disease

72	Neoplasms (Cancer) 06/2022 - 01/2009
17	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2013
15	Stomach Neoplasms (Stomach Cancer) 01/2019 - 06/2011
14	Breast Neoplasms (Breast Cancer) 02/2022 - 02/2012
8	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2013
5	Glioma (Gliomas) 01/2022 - 12/2019
5	Carcinogenesis 01/2022 - 09/2013
5	Prostatic Neoplasms (Prostate Cancer) 08/2017 - 02/2013
4	Hypoxia (Hypoxemia) 06/2022 - 03/2016
4	Carcinoma (Carcinomatosis) 06/2022 - 02/2013
3	Esophageal Squamous Cell Carcinoma 12/2022 - 11/2015
3	Colonic Neoplasms (Colon Cancer) 06/2022 - 10/2017
3	Lymphatic Metastasis 06/2022 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 10/2017
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021 - 01/2019
3	Wounds and Injuries (Trauma) 11/2021 - 06/2019
3	Scoliosis 07/2020 - 06/2016
3	Osteosarcoma (Osteogenic Sarcoma) 06/2020 - 01/2018
3	Inflammation (Inflammations) 01/2020 - 06/2018
2	Intrahepatic Cholestasis of Pregnancy 07/2022 - 01/2022
2	Triple Negative Breast Neoplasms 02/2022 - 12/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 03/2020
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2022
2	Pain (Aches) 01/2022 - 07/2021
2	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 10/2021
2	Fibrosis (Cirrhosis) 09/2021 - 08/2020
2	COVID-19 01/2020 - 01/2020
2	Pre-Eclampsia (Preeclampsia) 01/2020 - 07/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 08/2018
2	Hyperglycemia 01/2020 - 07/2018
2	Infections 01/2020 - 06/2012
2	Ovarian Epithelial Carcinoma 02/2019 - 06/2017
2	Intervertebral Disc Displacement (Herniated Disc) 01/2017 - 07/2016

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 06/2021 - 12/2009
9	MicroRNAs (MicroRNA)IBA 02/2022 - 07/2015
9	Biological ProductsIBA 01/2022 - 04/2009
9	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2010
8	Biomarkers (Surrogate Marker)IBA 07/2022 - 08/2017
7	Sorafenib (BAY 43-9006)FDA Link 03/2021 - 01/2018
6	RNA (Ribonucleic Acid)IBA 02/2022 - 03/2014
6	Pharmaceutical PreparationsIBA 06/2020 - 06/2015
5	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 08/2018
5	Carcinoembryonic AntigenIBA 01/2022 - 01/2016
5	LigandsIBA 01/2018 - 02/2013
4	Interleukin-10 (Interleukin 10)IBA 01/2022 - 06/2010
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2012
4	AntigensIBA 01/2022 - 12/2013
4	CarbohydratesIBA 01/2022 - 01/2016
4	Trastuzumab (Herceptin)FDA Link 08/2018 - 05/2012
4	Estrogen ReceptorsIBA 01/2018 - 02/2012
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2018 - 01/2016
3	EnzymesIBA 02/2022 - 01/2020
3	InterleukinsIBA 01/2022 - 06/2010
3	CateninsIBA 01/2022 - 01/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2018
3	LipidsIBA 01/2022 - 07/2018
3	CollagenIBA 01/2022 - 11/2017
3	CalciumIBA 01/2022 - 06/2011
3	TitaniumIBA 11/2020 - 08/2009
3	Insulin (Novolin)FDA Link 01/2020 - 08/2018
3	Phosphotransferases (Kinase)IBA 12/2019 - 07/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2019 - 01/2018
3	Blood Group Antigens (Blood Groups)IBA 11/2017 - 10/2015
2	CarbonIBA 05/2022 - 04/2020
2	Glutamine (L-Glutamine)FDA Link 02/2022 - 01/2021
2	Epidermal Growth Factor (EGF)IBA 02/2022 - 08/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 02/2016
2	Histones (Histone)IBA 01/2022 - 10/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
2	Neutralizing AntibodiesIBA 01/2022 - 07/2021
2	Sterol Regulatory Element Binding Protein 1IBA 01/2022 - 11/2019
2	CytokinesIBA 01/2022 - 07/2021
2	Pregnane X ReceptorIBA 03/2021 - 04/2018
2	rhamnetinIBA 03/2021 - 07/2016
2	InflammasomesIBA 01/2021 - 06/2018
2	HydrogelsIBA 08/2020 - 06/2019
2	C-Reactive ProteinIBA 01/2020 - 07/2018
2	AntibodiesIBA 01/2020 - 05/2016
2	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 06/2017
2	Liver X ReceptorsIBA 01/2019 - 01/2018
2	Substance PIBA 01/2019 - 06/2011
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2019 - 06/2011
2	Messenger RNA (mRNA)IBA 11/2018 - 08/2017
2	Fibronectins (Fibronectin)IBA 08/2018 - 08/2017
2	Cadherins (E-Cadherin)IBA 08/2018 - 07/2013
2	Interleukin-17 (Interleukin 17)IBA 07/2018 - 02/2013
2	SolutionsIBA 06/2018 - 01/2018
2	CalreticulinIBA 01/2018 - 03/2015
2	Tumor Biomarkers (Tumor Markers)IBA 11/2017 - 11/2017
2	Notch ReceptorsIBA 11/2017 - 01/2009
2	Epirubicin (Ellence)FDA LinkGeneric 10/2017 - 10/2017

Therapy/Procedure

21	Therapeutics 12/2021 - 06/2010
14	Gastrectomy 01/2019 - 06/2013
13	Drug Therapy (Chemotherapy) 01/2022 - 02/2013
4	Radiotherapy 12/2019 - 09/2015
3	Blood Transfusion (Blood Transfusions) 07/2022 - 07/2020
3	Immunotherapy 07/2020 - 04/2010
2	Qigong (Qi Gong) 11/2021 - 01/2020
2	Operative Time 07/2020 - 02/2017
2	Operative Surgical Procedures 05/2018 - 02/2017